[Pathogenesis and management of immune thrombocytopenia].
Kingo
K
Fujimura
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage; D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D001323:Autoantibodies; D001565:Benzoates / Q000008:administration & dosage; D001792:Blood Platelets / Q000276:immunology*; D003907:Dexamethasone / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D016481:Helicobacter Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011720:Pyrazoles / Q000008:administration & dosage; D053628:Receptors, Thrombopoietin / Q000819:agonists; D000069283:Rituximab; D013156:Splenectomy; D013921:Thrombocytopenia / Q000097:blood / Q000209:etiology / Q000276:immunology* / Q000628:therapy*
D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D001565:Benzoates; D006834:Hydrazines; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; D000069283:Rituximab; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; C520809:eltrombopag